Published: Wed, September 20, 2017
Business | By Max Garcia

Walgreens Boots Alliance Gets Regulatory OK For Amended Rite Aid Deal

Walgreens Boots Alliance Gets Regulatory OK For Amended Rite Aid Deal

The average investment recommendation on a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell) is 2.00, which implies that analysts are generally neutral in their outlook for WBA over the next year.

The average 1-year price target for AmerisourceBergen Corporation (ABC) - averaging the work of different analysts - reveals a mean PT of $91.67/share.

Want to see what other hedge funds are holding WBA? The rating was maintained by Pivotal Research on Thursday, June 29 with "Hold". The stock of Walgreens Boots Alliance Inc (NASDAQ:WBA) earned "Outperform" rating by Credit Suisse on Monday, July 18. Jefferies Group LLC reissued a buy rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a research note on Thursday, September 7th.

Walgreens Boots Alliance, Inc.is a holding company. The company had proposed to buy 2,186 Rite Aid stores for $5,175 billion in June after it terminated its planned merger with Rite Aid. Mackie upgraded it to "Speculative Buy" rating and $42.50 target in Monday, October 19 report. The firm has "Buy" rating given on Monday, October 17 by Jefferies.

Walgreens Boots Alliance (NASDAQ:WBA) opened at 81.21 on Tuesday. WBA 's 20-day moving average now sits below its 100-day moving average. Now trading with a market value of 86.39B, the company has a mix of catalysts and obstacles that spring from the nature of its operations.

The share price of the company (NASDAQ:WBA) was up +0.12%, with a high of 83.62 during the day and the volume of Walgreens Boots Alliance, Inc. shares traded was 6117199.

Wall Street await Walgreens Boots Alliance Inc (NASDAQ:WBA) to release earnings on October, 19.

When calculating EPS estimates for the current year from sell-side analysts, the Price to current year EPS stands at -97.60%. The business had revenue of $30.12 billion during the quarter, compared to analyst estimates of $29.72 billion.

02/06/2017 - Walgreens Boots Alliance, Inc. was upgraded to "overweight" by analysts at Atlantic Equities. The firm's revenue for the quarter was up 2.1% compared to the same quarter a year ago.

WARNING: This news story was originally published by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this story on another publication, it was illegally stolen and reposted in violation of worldwide copyright and trademark law. The legal version of this news story can be viewed at https://baseballnewssource.com/markets/needham-company-llc-reiterates-buy-rating-for-walgreens-boots-alliance-inc-wba/1649625.html.

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 12th. Investors of record on Friday, August 18th were given a $0.40 dividend. The ex-dividend date of this dividend was Wednesday, August 16th. This is a boost from Walgreens Boots Alliance's previous quarterly dividend of $0.38. This represents a $1.60 dividend on an annualized basis and a yield of 1.97%. Walgreens Boots Alliance's dividend payout ratio is now 40.30%.

Walgreens is the second-biggest pharmacy retail chain in the United States in terms of sales and market cap. (WBA) to generate earnings per share of $5.02 in 2017. Hudock Capital Group LLC now owns 1,300 shares of the pharmacy operator's stock valued at $108,000 after purchasing an additional 5 shares during the period.

The stock prices for Rite Aid and Walgreens fell 12% and 1.7%, respectively, after the news. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Among institutions that increased their positions, 88 were new positions. MCF Advisors LLC raised its position in Walgreens Boots Alliance by 68.2% in the first quarter. Finally, Founders Capital Management acquired a new stake in shares of Walgreens Boots Alliance in the 1st quarter valued at approximately $161,000. Finally, Loop Capital started coverage on shares of Walgreens Boots Alliance in a research report on Thursday, August 24th. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale.

Like this: